224 related articles for article (PubMed ID: 7453847)
1. Potential anticancer agents. XX. 2. Quantitative structure--activity relationships (QSAR) in aromatic nitrogen mustards area.
Niculescu-Duvăz I; Stihi G; Crăescu T; Simon Z
Neoplasma; 1980; 27(3):271-8. PubMed ID: 7453847
[TBL] [Abstract][Full Text] [Related]
2. Potential anticancer agents. XX. 1. Steric fit analysis in aromatic nitrogen mustards area.
Bădilescu II; Crăescu T; Niculescu-Duvăz I; Simon Z
Neoplasma; 1980; 27(3):261-9. PubMed ID: 7453846
[TBL] [Abstract][Full Text] [Related]
3. Potential anticancer agents. XVII. New developments in the benzoic acid nitrogen mustards area.
Niculescu-Duvăz I; Feyns V; Dobre V
Cancer Treat Rep; 1978 Dec; 62(12):2045-54. PubMed ID: 751714
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor action of phenylalanine derivatives of mechlorethamine (author's transl)].
Zhou JX; Liang HZ; Xu B
Zhongguo Yao Li Xue Bao; 1981 Jun; 2(2):121-8. PubMed ID: 6461211
[No Abstract] [Full Text] [Related]
5. Potential anticancer agents. XXII. Pharmacological properties of some new triazene derivatives.
Ionescu D; Neagu V; Dobre V; Niculescu-Duvaz I
Neoplasma; 1981; 28(1):19-26. PubMed ID: 7279057
[TBL] [Abstract][Full Text] [Related]
6. [Tumour chemotherapy: syntheses of N-phosphorylated nitrogen mustards and related compounds].
Kao WI; Ho HY; Song CW; Li MM; Cheng BL
Yao Xue Xue Bao; 1965 Oct; 12(10):672-7. PubMed ID: 5898992
[No Abstract] [Full Text] [Related]
7. 3D QSAR/CoMFA and CoMSIA studies on antileukemic steroidal esters coupled with conformationally flexible nitrogen mustards.
Kapou A; Benetis NP; Durdagi S; Nikolaropoulos S; Mavromoustakos T
J Chem Inf Model; 2008 Nov; 48(11):2254-64. PubMed ID: 18954137
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship of aniline mustards acting against B-16 melanoma in mice.
Panthananickal A; Hansch C; Leo A
J Med Chem; 1979 Oct; 22(10):1267-9. PubMed ID: 513075
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.
Atwell GJ; Yang S; Pruijn FB; Pullen SM; Hogg A; Patterson AV; Wilson WR; Denny WA
J Med Chem; 2007 Mar; 50(6):1197-212. PubMed ID: 17326614
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships in antitumor aniline mustards.
Panthananickal A; Hansch C; Leo A
J Med Chem; 1978 Jan; 21(1):16-26. PubMed ID: 619146
[TBL] [Abstract][Full Text] [Related]
11. QSAR of acridines. II. Features of nitracrine analogs for high anti-tumor activity and selectivity on mice, searched by PCA and MRA methods.
Mazerska Z; Mazerski J; Ledóchowski A
Anticancer Drug Des; 1990 May; 5(2):169-87. PubMed ID: 2357263
[TBL] [Abstract][Full Text] [Related]
12. Comparative QSAR in toxicology: examples from teratology and cancer chemotherapy of aniline mustards.
Hansch C; Telzer BR; Zhang L
Crit Rev Toxicol; 1995; 25(1):67-89. PubMed ID: 7734060
[TBL] [Abstract][Full Text] [Related]
13. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
Sugiura K; Merker PC
Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
[No Abstract] [Full Text] [Related]
14. Some antitumor agents derived from benzaldehyde nitrogen mustards.
Florvall L
Acta Pharm Suec; 1970 Apr; 7(2):87-104. PubMed ID: 5421623
[No Abstract] [Full Text] [Related]
15. QSAR of acridines, III. Structure-activity relationship for antitumour imidazoacridinones and intercorrelations between in vivo and in vitro tests.
Mazerska Z; Augustin E; Dziegielewski J; Chołody MW; Konopa J
Anticancer Drug Des; 1996 Jan; 11(1):73-88. PubMed ID: 8639249
[TBL] [Abstract][Full Text] [Related]
16. Antileukemic and cytogenetic activity by triple administration of three modified steroidal derivatives of nitrogen mustards.
Fousteris MA; Papageorgiou A; Arsenou ES; Koutsourea AI; Karaberis E; Mourelatos D; Onyango DO; Nikolaropoulos SS
Chemotherapy; 2007; 53(2):118-26. PubMed ID: 17308378
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of cyclic nitrogen mustards based on carnitine framework.
Leiris S; Lucas M; Dupuy d'Angeac A; Morère A
Eur J Med Chem; 2010 Sep; 45(9):4140-8. PubMed ID: 20615582
[TBL] [Abstract][Full Text] [Related]
18. Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.
Niculescu-Duvaz I; Scanlon I; Niculescu-Duvaz D; Friedlos F; Martin J; Marais R; Springer CJ
J Med Chem; 2004 May; 47(10):2651-8. PubMed ID: 15115406
[TBL] [Abstract][Full Text] [Related]
19. Molecular orbital calculations on tumour-inhibitory aniline mustards: QSARs.
Lewis DF
Xenobiotica; 1989 Feb; 19(2):243-51. PubMed ID: 2728496
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
